Pre and post vitrectomy infliximab in Bechet's disease posterior uveitis
Not Applicable
Completed
- Conditions
- Bechet's disease posterior uveitisEye Diseases
- Registration Number
- ISRCTN20489230
- Lead Sponsor
- Cairo University
- Brief Summary
1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28484648 (added 29/01/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. Bechet's disease persistent posterior uveitis not responding to systemic treatment
2. Eyes with dense persistent vitreous opacities
3. Eyes with epiretinal membranes
4. Persistent macular edema
5. Age 18-60 years
Exclusion Criteria
1. Patients with active infections
2. End-stage disease
3. Impaired liver function, leucopenia and thrombocytopenia
4. Patients receiving immunosuppressants other than corticosteroids at time of application of the drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method